MedPath

A new approach to determine the time of incidence of traumatic brain injury with chronic subdural hematomas.

Completed
Conditions
traumatisch hersenletsel
Chronic Subdural Hematomas - Traumatic Brain Injury
10007963
Registration Number
NL-OMON42525
Lead Sponsor
Academisch Medisch Centrum
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
Completed
Sex
Not specified
Target Recruitment
15
Inclusion Criteria

* 18 years.
Mentally competent.
Informed consent.
CSDH as a consequence of traumatic brain injury (TBI).
Month of incidence of TBI is known.

Exclusion Criteria

< 18 years.
Not mentally competent.
CSDH not as a consequence of TBI.
Unknown time of incidence of TBI.

Study & Design

Study Type
Observational invasive
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
<p>The concentration of 6 biomarkers (proteins) in the serum of the CSDH will be<br /><br>measured with an immunosorbent assay (ELISA) in order to determine the age of<br /><br>the CSDH.</p><br>
Secondary Outcome Measures
NameTimeMethod
<p>Subsequently, the CSDH will be examined with reflection spectroscopy in order<br /><br>to measure the amount of hemoglobine derivatives in the CSDH.<br /><br></p><br>
© Copyright 2025. All Rights Reserved by MedPath